| Market Cap | 477.09K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -53.38k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -9.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -37.00% |
| Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -82.00% | |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 12.49B | 52W Low Chg | 19.00% |
| Insider Own | - | ROA | - | Shares Float | - | Beta | 0.87 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00080 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 424,738 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 20,000 | Change | 0.00% |
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.
